Preventing blindness by improving retinal therapy with AI
Innovative Solution
deepeye is a precision medicine platform for retinal diseases. It enables ophthalmologists to provide individual therapy to patients suffering from prevalent eye diseases like Age-related Macular Degeneration (AMD) or other retinal diseases which affect 12% of the EU+US population, thus preventing the causes of more than 66% of blindness’.
Investment Funding
Last Funding Stage
Seed
Total Funding Amount
2.67M
Last Funding Amount
2.67M
Last Funding Date
07-11-2023
Startup Stage
Seed
Lead Investors
Bayern Kapital, YZR Capital, Arve Capital, Springboard Health Angels
People
Founders
Manuel Opitz
About
deepeye® is a precision medicine platform for retinal diseases. It enables ophthalmologists to provide individual therapy to patients suffering from prevalent eye diseases like Age-related Macular Degeneration (AMD) or other retinal diseases which affect 12% of the EU+US population, thus preventing the causes of more than 66% of blindness’.
Something missing or incorrect on this page? Help us enrich this information
